These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The effect of ethyldeshydroxy-sparsomycin and cisplatin on the intracellular glutathione level and glutathione S-transferase activity. Hofs HP, Wagener TD, de Valk-Bakker V, van Rennes H, Doesburg WH, Ottenheijm HC, de Grip WJ. Anticancer Drugs; 1997 Apr; 8(4):349-57. PubMed ID: 9180388 [Abstract] [Full Text] [Related]
8. Mechanisms of resistance of human small cell lung cancer lines selected in VP-16 and cisplatin. Jain N, Lam YM, Pym J, Campling BG. Cancer; 1996 May 01; 77(9):1797-808. PubMed ID: 8646677 [Abstract] [Full Text] [Related]
9. Human renal UOK130 tumor cells: a drug resistant cell line with highly selective over-expression of glutathione S-transferase-pi isozyme. Wang W, Liu G, Zheng J. Eur J Pharmacol; 2007 Jul 30; 568(1-3):61-7. PubMed ID: 17509556 [Abstract] [Full Text] [Related]
10. The relationships between glutathione, glutathione-S-transferase and cytotoxicity of platinum drugs and melphalan in eight human ovarian carcinoma cell lines. Mistry P, Kelland LR, Abel G, Sidhar S, Harrap KR. Br J Cancer; 1991 Aug 30; 64(2):215-20. PubMed ID: 1892748 [Abstract] [Full Text] [Related]
11. Establishment and characterization of a cisplatin-resistant human neuroblastoma cell line. Yasuno T, Matsumura T, Shikata T, Inazawa J, Sakabe T, Tsuchida S, Takahata T, Miyairi S, Naganuma A, Sawada T. Anticancer Res; 1999 Aug 30; 19(5B):4049-57. PubMed ID: 10628353 [Abstract] [Full Text] [Related]
12. A study of ethacrynic acid as a potential modifier of melphalan and cisplatin sensitivity in human lung cancer parental and drug-resistant cell lines. Rhodes T, Twentyman PR. Br J Cancer; 1992 May 30; 65(5):684-90. PubMed ID: 1316774 [Abstract] [Full Text] [Related]
13. Modulation of cisplatin sensitivity and accumulation by interferon alpha-2A in human squamous carcinoma cell lines. Gupta V, Jani JP, Emerson EO, Xu BH, Scalamogna D, Xia H, Katoh A, Zaren HA, Singh SV. Int J Cancer; 1995 Nov 03; 63(3):419-22. PubMed ID: 7591242 [Abstract] [Full Text] [Related]
14. Glutathione S-transferase pi amplification is associated with cisplatin resistance in head and neck squamous cell carcinoma cell lines and primary tumors. Cullen KJ, Newkirk KA, Schumaker LM, Aldosari N, Rone JD, Haddad BR. Cancer Res; 2003 Dec 01; 63(23):8097-102. PubMed ID: 14678959 [Abstract] [Full Text] [Related]
15. In vitro platinum drug chemosensitivity of human cervical squamous cell carcinoma cell lines with intrinsic and acquired resistance to cisplatin. Mellish KJ, Kelland LR, Harrap KR. Br J Cancer; 1993 Aug 01; 68(2):240-50. PubMed ID: 8347478 [Abstract] [Full Text] [Related]
16. Brostallicin, a novel anticancer agent whose activity is enhanced upon binding to glutathione. Geroni C, Marchini S, Cozzi P, Galliera E, Ragg E, Colombo T, Battaglia R, Howard M, D'Incalci M, Broggini M. Cancer Res; 2002 Apr 15; 62(8):2332-6. PubMed ID: 11956092 [Abstract] [Full Text] [Related]
17. Modulation of cisplatin resistance in acquired-resistant nonsmall cell lung cancer cells. Lai SL, Hwang J, Perng RP, Whang-Peng J. Oncol Res; 1995 Apr 15; 7(1):31-8. PubMed ID: 7549042 [Abstract] [Full Text] [Related]
18. Characteristics of the glutathione/glutathione-S-transferase detoxification system in melphalan resistant human prostate cancer cells. Ripple M, Mulcahy RT, Wilding G. J Urol; 1993 Jul 15; 150(1):209-14. PubMed ID: 8510259 [Abstract] [Full Text] [Related]
19. Mechanistic study of potentiation of chemotherapy by a haloenol lactone derivative in vitro. Wang W, Xia CQ, Liu N, Gan LS, Zheng J. Cancer Chemother Pharmacol; 2008 Jun 15; 62(1):117-22. PubMed ID: 17899085 [Abstract] [Full Text] [Related]